{"CVE": "CVE-2025-61940", "CWE": ["CWE-603"], "DATE": "2025-12-02 21:15:51", "SCORE": 8.3, "METRIC": "CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:L", "TITLE": "Mirion Medical EC2 Software NMIS BioDose Use of Client-Side Authentication", "DESC": "NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.", "PRODUIT": ["mirion", "mirion$PRODUCT$biodose\\/nmis"]}